Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Net Income towards Common Stockholders (2017 - 2025)

Inspire Medical Systems' Net Income towards Common Stockholders history spans 9 years, with the latest figure at $136.1 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 286.71% year-over-year to $136.1 million; the TTM value through Dec 2025 reached $145.4 million, up 171.79%, while the annual FY2025 figure was $145.4 million, 171.77% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $136.1 million at Inspire Medical Systems, up from $9.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $136.1 million in Q4 2025 and bottomed at -$16.8 million in Q3 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$6.1 million (2023), against an average of $4.5 million.
  • The largest annual shift saw Net Income towards Common Stockholders skyrocketed 369.62% in 2023 before it plummeted 136.07% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$2.4 million in 2021, then skyrocketed by 231.74% to $3.2 million in 2022, then surged by 369.62% to $14.8 million in 2023, then surged by 137.9% to $35.2 million in 2024, then skyrocketed by 286.71% to $136.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Net Income towards Common Stockholders are $136.1 million (Q4 2025), $9.9 million (Q3 2025), and -$3.5 million (Q2 2025).